A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with Coronary Artery Disease) trial-Reference-Cited by-同舟云学术

A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with Coronary Artery Disease) trial

Published:2014-05-19 Issue:30 Volume:35 Page:2021-2031
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:European Heart Journal

Author:

Saito S.,Valdes-Chavarri M.,Richardt G.,Moreno R.,Iniguez Romo A.,Barbato E.,Carrie D.,Ando K.,Merkely B.,Kornowski R.,Eltchaninoff H.,James S.,Wijns W.,

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/35/30/2021/17354542/ehu210.pdf

Reference30 articles.

1. Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

2. Comparison of an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients With Coronary Artery Disease

3. Balancing Efficacy and Safety of Drug-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention

4. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis

5. A Cause for Concern

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. One-Month Dual Antiplatelet Therapy Followed by P2Y<sub>12</sub> Inhibitor Monotherapy After Biodegradable Polymer Drug-Eluting Stent Implantation　― The REIWA Region-Wide Registry ―;Circulation Journal;2024-05-24

2. Revolutionizing Cardiovascular Frontiers: A Dive Into Cutting-Edge Innovations in Coronary Stent Technology;Cardiology in Review;2024-05-06

3. OPTImized coronary interventions eXplaIn the bEst cliNical outcomEs (OPTI-XIENCE) study. Rationale and study design;Cardiovascular Revascularization Medicine;2024-02

4. Variability in research culture across busy catheterisation labs in the Asia-Pacific region;AsiaIntervention;2024-02

5. Comparative efficacy of different Chinese patent medicines in preventing restenosis after percutaneous coronary intervention: a systematic review and Bayesian network meta-analysis of randomized clinical trials;Frontiers in Pharmacology;2024-01-05